TERRAMAC TE-7003 Low Density Antibacterial Injection Molding Polylactic Acid is specified as a compounded polylactic acid (PLA) grade for high-cavitation injection molding, combining reduced part mass with an antibacterial surface function. The base polymer is a semicrystalline polyester derived from fermentative lactic acid; the low-density and antibacterial modifications are introduced during melt compounding and are intended to remain dispersed through the melt phase. The grade is positioned for rigid consumer, personal-care, packaging, and hygiene-related components that require measurable microbial reduction on the as-molded surface. Because the manufacturer’s public datasheet does not always publish full compositional and lot-specific mechanical values, molders should obtain a current certificate of analysis and qualify the material on the target tool before production release.

Material Architecture and Process-Property Interactions

Material architecture in TERRAMAC TE-7003 is best understood as a two-level modification of a PLA matrix. The resin is an injection-molding-grade polylactic acid with melt rheology adjusted for thin-wall fill; the low-density designation indicates that the compounded specific gravity is lower than that of a comparable mineral-filled or high-crystallinity PLA grade, although the exact density-reduction strategy is not disclosed in all public regional datasheets. If the reduction is achieved through microcellular void formation, the packing phase behavior differs from that of solid PLA; if it is achieved through a low-density filler, the screw-recovery and venting characteristics will be closer to conventional filled systems. The antibacterial modification is typically an inorganic additive dispersed in the melt. Because silver-based antibacterial agents can be redox-sensitive at elevated temperature, local melt temperature and residence time become the primary limits on process robustness. The base polymer remains subject to hydrolytic degradation, so moisture control is not a secondary consideration.

Thermal degradation in PLA proceeds through random chain scission, lactide regeneration, and hydrolysis. At melt temperatures above 210 °C, molecular weight reduction can proceed at a rate that depends on residual moisture and residence time. Degradation products include lactide and oligomeric acids, which can accelerate further hydrolysis. In antibacterial grades, acid generation can also destabilize silver carriers and shift surface coloration. Processing windows should therefore be bounded by melt residence time and temperature, not only by fill pressure. Capillary rheometry at 190–210 °C for injection-molding PLAs typically yields a shear-thinning power-law index of 0.6–0.8; the consistency index depends on molecular weight, moisture, and the low-density modification. In a hot-runner high-cavitation tool, pressure drop across the manifold should be calculated with a shear viscosity measured at the actual gate shear rate. Because TERRAMAC TE-7003 incorporates a low-density modification, the melt compressibility can be higher than that of unmodified PLA; holding pressure should be profiled using gate-freeze time rather than a fixed timer.

Before melt processing, predrying in a desiccant dryer is specified for PLA-class materials to reduce moisture content below 250 ppm as measured by ISO 15512:2019. A drying schedule of 80 °C for 4 h with a dryer dew point of -40 °C or lower is class-typical. Hopper residence time at drying temperature should not exceed 6 h to avoid lactide formation and bridging. On production-scale injection molding lines with clamping forces from 800 kN to 3,000 kN, the principal processing bottleneck for low-density PLA grades is frequently not clamp force but screw recovery and gas venting, particularly when the density reduction creates a more compressible melt. Parting-line vents of 0.02–0.03 mm depth or vacuum-vented tools are often required to prevent burn marks and gas entrapment. Melt temperature should be profiled from rear to nozzle within the range 180–210 °C unless the certificate of analysis states otherwise; prolonged operation above 210 °C can accelerate molecular weight loss and reduce antibacterial activity.

What Limits the Antibacterial Additive’s Survival During High-Shear Injection Molding?

Antibacterial agents in PLA compounds can lose efficacy through thermal decomposition, additive agglomeration, or surface migration during melt processing. Class-typical molding trials on reciprocating-screw machines indicate that melt temperatures above 210 °C and cumulative residence time beyond 10–15 min can shift ISO 22196:2011 activity from greater than 2 log10 reduction toward marginal performance; these values are not a substitute for TERRAMAC TE-7003 lot-specific data. Screw geometry with a three-zone general-purpose design, length-to-diameter ratio between 20:1 and 24:1, and compression ratio between 2.5:1 and 3.5:1 is commonly used. Back pressures of 2–8 MPa and moderate screw rotation are preferred to limit shear heating. Small gates can generate high local shear rates; mold-fill simulation should keep gate shear rates below 50,000 s⁻¹ as a starting limit for silver-based antibacterial systems, though published data for this specific configuration is limited.

Process capability studies on a 16-cavity hot-runner tool for similar low-density PLA grades have shown that shot-to-shot part mass can vary by 0.2–0.5% when screw recovery speed is too high, while melt volume-flow rate remains within specification. A recurring failure mode is gate blush caused by gas breakout from the melt at the gate; venting and lower melt temperature reduce the defect. Another observed failure mode is variability in antibacterial performance between cavities, often caused by non-uniform residence time in hot-runner manifolds. Cavity-specific validation is therefore required. The molder should establish a screw-recovery profile that avoids over-shearing the low-density melt and maintain a cushion between 3–6 mm.

The following class-typical reference data for unfilled injection-molding PLA are provided as a comparative baseline; they are not a certificate of analysis for TERRAMAC TE-7003 and should be superseded by lot-specific measurements.

Compared with general-purpose PLA injection molding grades, TERRAMAC TE-7003 adds two concurrent property modifications: reduced part mass and antibacterial surface activity. The trade-off is a narrower processing window because both modifications alter melt rheology and thermal stability. In comparison with mineral-filled PLA, the low-density designation avoids the density increase associated with talc or calcium carbonate loadings of 10–20 wt%, which can raise compounded density to 1.35–1.45 g/cm³. Compared with antimicrobial ABS or polypropylene compounds, TE-7003 retains the bio-based carbon content and hydrolytic degradation profile of PLA; however, it also inherits PLA’s lower heat deflection temperature and requires crystallinity management or annealing for service above 55 °C under load. Bio-based carbon content can be quantified by ASTM D6866, while industrial composting certification, where applicable, is evaluated under EN 13432 or ASTM D6400; the antibacterial modification may affect compostability and must be confirmed with the grade-specific documentation.

If Low Density Is Maintained Through Thick Sections, Mold Temperature Becomes Critical

When low-density modification is produced by microcellular void formation, the packing phase is shortened and sink marks are mitigated, but the insulating void structure reduces effective thermal diffusivity. Mold temperature then controls the freeze-off rate and the development of the amorphous skin. For thin-wall parts below 1.5 mm, mold temperatures of 20–40 °C are typical for fast cycle and dimensional stability; for sections above 3 mm or where heat resistance is specified, mold temperatures of 90–110 °C promote crystallization and raise heat deflection temperature. Part ejection and cycle time must accommodate the slower annealing step. In production tools, conformal cooling channels are beneficial when crystallinity is required in thick sections because non-uniform mold temperature can produce differential shrinkage and warpage.

Crystallization of PLA is relatively slow compared with polypropylene. Isothermal crystallization half-times for PLA can range from 2 min to 20 min depending on stereochemistry and nucleating agents. In low-density grades, the presence of voids or low-density fillers may further reduce thermal conductivity, slowing cooling and modifying crystallization. Cycle-time increases of 30–60 s can occur in thick sections when mold temperature is raised to induce crystallinity. Published data for TE-7003-specific crystallization half-times is limited; the molder should map crystallization behavior using differential scanning calorimetry on the actual compounded resin.

Before committing to production, the molder should obtain a current certificate of analysis for TERRAMAC TE-7003 and confirm three parameters: moisture content after drying, melt volume-flow rate at 210 °C/2.16 kg, and antibacterial log reduction after molding. The antibacterial claim is not established by the resin certificate alone; it must be revalidated on the final molded part geometry, because gate shear, mold temperature, and post-molding aging can affect additive distribution. Published data for this specific configuration is limited in public sources; therefore, a design of experiments across melt temperature, injection speed, and hold pressure is warranted. Molded parts intended for food-contact or medical applications require separate regulatory review under the applicable FDA 21 CFR, EU 10/2011, or ISO 10993-5 pathway, and antibacterial efficacy claims are subject to regional biocide registration requirements.